Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.06M Hold
378,551
0.12% 53
2026
Q1
$3.4M Sell
378,551
-1
-0% -$7 0.09% 52
2025
Q4
$2.09M Hold
378,552
0.08% 10
2025
Q3
$1.51M Hold
378,552
0.08% 9
2025
Q2
$1.02M Hold
378,552
0.05% 9
2025
Q1
$1.98M Hold
378,552
0.04% 28
2024
Q4
$2.91M Hold
378,552
0.05% 31
2024
Q3
$3.54M Hold
378,552
0.06% 33
2024
Q2
$4.06M Hold
378,552
0.06% 31
2024
Q1
$5.6M Hold
378,552
0.11% 31
2023
Q4
$7.24M Hold
378,552
0.12% 33
2023
Q3
$10.2M Hold
378,552
0.18% 33
2023
Q2
$17.1M Hold
378,552
0.25% 33
2023
Q1
$17.3M Hold
378,552
0.28% 32
2022
Q4
$19.9M Hold
378,552
0.39% 33
2022
Q3
$43.8M Hold
378,552
0.72% 26
2022
Q2
$22.9M Hold
378,552
0.35% 31
2022
Q1
$21.1M Hold
378,552
0.26% 34
2021
Q4
$28.9M Buy
+378,552
New +$44M 0.29% 35

Other funds holding RLYB

TPG GP A's RLYB Position: Q2 2026 in Review

TPG GP A held its Rallybio (RLYB) position steady in Q2 2026 at 378,551 shares worth $6.06M. The position accounts for 0.12% of the portfolio, ranked #53.

TPG GP A first reported a position in RLYB in Q4 2021 and has held it in 19 quarters since. The position peaked at $43.8M in Q3 2022. 37 funds tracked by Wall St. Rank hold RLYB as of Q2 2026.

  • TPG GP A held 378,551 shares of Rallybio worth $6.06M as of Q2 2026.
  • TPG GP A left its Rallybio share count unchanged in Q2 2026.
  • Rallybio made up 0.12% of TPG GP A's portfolio in Q2 2026, its #53 holding.
  • TPG GP A first reported a position in Rallybio in Q4 2021 and has held it in 19 quarters since.
  • TPG GP A's Rallybio position peaked at $43.8M in Q3 2022.
  • 37 funds tracked by Wall St. Rank held Rallybio as of Q2 2026.

Based on TPG GP A's 13F filing for Q2 2026, filed 14 Aug 2026.